The group's principal activity is to provide outsource drug development research services for pharmaceutical and biotechnology industries. It also manages clinical trials at multiple sites involving ophthalmology, dermatology and generic drug testing. The group conducts clinical trials and provides related services to pharmaceutical, biotechnology and contract research organizations. Clinical research involves the testing of new drugs and other products on humans according to guidelines set by clients and approved by the fda. The group has operations in the United States, Canada, Spain, North America, Europe and Asia. The group acquired clinical pharmacology of Florida inc on 04-Aug-2003, synfine research inc on 26-Mar-2003 and remaining 51% interest in danapharm clinical research inc on 07-Jul-2003. The group acquired taylor technology inc on 26-Jul-2004.
